JPRN-UMIN000031095已完成未知
sefulness of FDG-PET/CT examination as prediction of effect of immune checkpoint inhibitors in patients with non-small cell lung cancer : a pilot study - Usefulness of FDG-PET/CT as prediction of effect of immune checkpoint inhibitors in lung cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with serious liver dysfunction or renal dysfunction 2)Pregnant or lactating females 3)Patients with clinically significant psychiatric disease that would interfere with participation in this study 4)Patients with history of previous immune checkpoint inhibitor treatment 5)Patients with history of autoimmune diseases 6)Patients with serious interstitial lung disease or infection
研究者
相似试验
尚未招募
不适用
sefulness of FDG-PET/CT to predict the response after anti-PD-1 antibody in patients with previously treated advanced non-small cell lung cancer: a multi-institutional studyPreviously treated advanced non-small cell lung cancerJPRN-UMIN000031009Gunma University120
招募中
不适用
sefulness of FDG-PET/CT to predict the response after nivolumab in patients with previously treated advanced non-small cell lung cancerPreviously treated advanced non-small cell lung cancerJPRN-UMIN000020814Gunma30
未知
不适用
sefulness of FDG-PET/CT to predict the response after pembrolizumab in patients with PD-L1 positive advanced non-small cell lung canceradvanced non-small cell lung cancerJPRN-UMIN000026730Gunma University Hospital50
进行中（未招募）
不适用
se of the PET-Scan examination in the evaluation of the treatment of patients diagnosed with Head and Neck CancerScamous Cell- Carcinoma of Head and NeckNeoplasmsPositron Emission Tomography Computed TomographyC04.557.470.200.400E01.370.350.350.800.700.500RBR-9wwstdAC Camargo Cancer Center
招募中
1 期
FDG-PET study for pulmonary MAC and CPAJPRN-jRCTs071190035Takazono Takahiro15